Lannett (LCI) Completes Voluntary Strategic Review; Affirms Acting in Compliance on Digoxin Pricing
Tweet Send to a Friend
Lannett (NYSE: LCI) announced that upon receipt of the subpoena from the State of Connecticut Office of the Attorney General ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
